Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inmune Bio Inc (NQ: INMB ) 5.140 +0.120 (+2.39%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Inmune Bio Inc < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 20, 2024 Via Benzinga INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023 March 28, 2024 INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace INmune Bio: Q4 Earnings Insights March 28, 2024 Via Benzinga A Preview Of INmune Bio's Earnings March 27, 2024 Via Benzinga Why Is Elevai Labs (ELAB) Stock Up Today? January 16, 2024 Elevai Labs is soaring on an intriguing licensing agreement with INmune Bio, but the narrative presents a mixed bag for ELAB stock. Via InvestorPlace Earnings Outlook For INmune Bio August 04, 2023 Via Benzinga INmune Bio's Earnings Outlook May 02, 2023 Via Benzinga INmune Bio Earnings Perspective: Return On Capital Employed March 08, 2023 Via Benzinga Earnings Preview: INmune Bio March 01, 2023 Via Benzinga INmune Bio's INKmune Shows Positive Efficacy In Multiple Cancer Cell Lines October 19, 2022 Via Benzinga Earnings Scheduled For March 28, 2024 March 28, 2024 Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. Via Benzinga Why Elevai Labs Stock Is Trading Higher January 16, 2024 Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 19, 2023 It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning! Via InvestorPlace Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning November 17, 2023 Biotech companies are edging closer to finding the answers behind Alzheimer's disease. Via Investor's Business Daily INmune Bio – Helping Your Own Cells Fight Cancer And Reverse Alzheimer's Disease June 13, 2023 David Moss, CEO of INmune Bio (NASDAQ: INMB) was recently a guest on Benzinga’s All-Access. Via Benzinga The 7 Best Biotech Stocks for Personalized Medicine Investors April 25, 2023 Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023 June 01, 2023 Via Benzinga Dow Jumps 250 Points; US Jobless Claims Increase Last Week February 09, 2023 U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose,... Via Benzinga Nasdaq Tumbles 150 Points; Crude Oil Up 1.5% February 08, 2023 U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 150 points on Wednesday. The Dow traded down 0.27% to 34,063.42 while the NASDAQ fell 1.33% to 11,952.51. The... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 25, 2023 Via Benzinga Recap: INmune Bio Q2 Earnings August 03, 2022 INmune Bio (NASDAQ:INMB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune Bio beat estimated... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 24, 2022 Via Benzinga The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures May 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 71 Biggest Movers From Yesterday May 25, 2022 Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7... Via Benzinga The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study May 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 50 Stocks Moving In Tuesday's Mid-Day Session May 24, 2022 Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million. Via Benzinga A Preview Of INmune Bio's Earnings May 04, 2022 INmune Bio (NASDAQ:INMB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that INmune Bio will... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 May 24, 2022 Upgrades Via Benzinga 60 Biggest Movers From Yesterday April 26, 2022 Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.